Abstract
Chemoresistance during treatment of osteosarcoma (OS) is attracting more and more attention as the main clinical obstacle. The purpose of this study was to elucidate the role of miR-340 in chemoresistance of OS. Plasmid construction and transfection, miRNA arrays, PCR analyses, and western blot analysis, as well as MTT, apoptosis, and luciferase assays were carried out in MG-63 cells and MG-63/cisplatin (DDP)-resistant cells. The results showed that miR-340 was downregulated in OS tissues and drug-resistant OS cells. Moreover, a negative correlation was observed between miR-340 and ZEB1 expression in OS tissues. Forced expression of miR-340 in drug-resistant OS cells significantly reduced multidrug resistance-1 and P-gp expression. Overexpression of miR-340 enhanced sensitivity to DDP by inhibiting viability and promoting apoptosis. The luciferase assay and western blot analysis identified ZEB1 as a direct target of miR-340, and miR-340 negatively regulated ZEB1 expression. Ectopic expression of ZEB1 reversed the effects of miR-340 on P-gp expression, cell viability, and apoptosis. miR-340 alleviated chemoresistance of OS cells by targeting ZEB1. Our results indicate that targeting miR-340 may be a potential therapeutic approac...Continue Reading
References
Apr 10, 2013·The Pharmacogenomics Journal·G AbsengerH-J Lenz
Apr 23, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shibing GuoWenxuan Wang
Jan 6, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Liang ShiFang Zheng
Sep 27, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yugang LiuJunli Chen
Oct 2, 2015·Current Medicinal Chemistry·Kai WangMeihua Sui
Dec 29, 2015·Oncology Reports·Ruida XuLifeng Lao
Apr 2, 2016·Oncotarget·Li-Kun HouXu-Chen Cao
May 11, 2016·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Peiquan LiQing Liu
Oct 21, 2016·Journal of Neuro-oncology·Cody L NesvickZhengping Zhuang
Dec 22, 2016·Biochemical and Biophysical Research Communications·Jianyong YuanJunhua Lu
Mar 25, 2017·International Journal of Oncology·Ming HeYonghui Fu
Mar 30, 2017·Oncology Reports·Ruirui ChengGuoqiang Zhao
Apr 27, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·L SongQ Zhou
Jun 24, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jiayong QiuYimin Mao
Jul 1, 2017·Experimental Cell Research·Yi ZhangWencai Li
Jul 6, 2017·International Journal of Molecular Medicine·Xuanhe SongWeiliang Yang
Citations
Oct 15, 2018·Journal of Cellular Physiology·Hsiao-Chi TsaiChih-Hsin Tang
Sep 2, 2018·Journal of Cellular Physiology·Qi WangXue-Jun Shao
Nov 2, 2019·Cancer Biotherapy & Radiopharmaceuticals·Jicheng WangZhi Yi
Jul 28, 2019·Current Pharmaceutical Biotechnology·Ling ChenJingyun Li
Nov 2, 2019·Journal of Cellular and Molecular Medicine·Xiaolong YuanXilong Wang
Mar 14, 2019·Molecular Medicine Reports·Jun HeYanshui Lin
Jan 19, 2019·Oncology Letters·Hao JinWenbo Wang
Jul 16, 2020·Biomolecules·Milad AshrafizadehAlan Prem Kumar
May 23, 2020·OncoTargets and Therapy·Ling Liu, Shuya Wang
Apr 15, 2019·Pathology Oncology Research : POR·Chenggang YangXiaofeng Shi
Mar 4, 2020·Molecular Cancer·Xinyi ZhangYongguang Tao
Dec 19, 2020·Open Medicine·Guanyu ZhangZhenfang Xiong
Feb 16, 2021·Cancer Letters·Zhengjun LinTang Liu
Jul 23, 2021·Molecular and Cellular Biochemistry·Lívia FratiniRafael Roesler